Recently Posted Guidance Documents on Administrative / Procedural, and Blood

Administrative / Procedural 12/28/2017 -  Best Practices for Communication Between IND Sponsors and FDA During Drug Development 12/28/2017 -  Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Guidance for Industry Blood 12/28/2017 -  Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry; Guidance for Industry 12/26/2017 -  Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers; Draft Guidance for Industry